DrugPatentWatch Database Preview
Details for Patent: 7,265,117
Which drugs does patent 7,265,117 protect, and when does it expire?
Patent 7,265,117 protects QOLIANA and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 7,265,117
| Title: | Topical brimonidine tartrate formulations that lack chlorine dioxide |
| Abstract: | Topical solution compositions of brimonidine tartrate are disclosed. The solution compositions lack an oxidative preservative. |
| Inventor(s): | Espino; Ramon L. (Cleburne, TX), Bhagat; Haresh G. (Fort Worth, TX) |
| Assignee: | Alcon, Inc. (Hunenberg, CH) |
| Application Number: | 11/122,651 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 7,265,117
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz Inc | QOLIANA | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021764-001 | May 22, 2006 | AT | RX | No | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,265,117
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2505836 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
